Vancouver, BC / February 25, 2021 / BioHarvest Sciences Inc. (the “Company”, “BioHarvest”) (CSE: BHSC) announces that it has granted a total of 6,000,000 stock options to the Company’s Chief Technical Officer, Dr Yochi Hagay. The stock options granted are exercisable to purchase a common share of the Company at a price of $0.66 per […]
BIOHARVEST SCIENCES INC. ANNOUNCES GRANT OF STOCK OPTIONS Read More »
This project will highlight the sustainability credentials and advantages of BioHarvest’s BioFarming technology. Vancouver, BC / February 16, 2021 / BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC)announces that it has entered into a partnership with BOLDT AG, an international business strategy and communications consultancy based in Europe, and Summit Strategy Group LLC, a
This milestone is critical for the large-scale production of full-spectrum plant-based cannabis products and cannabinoids in liquid media bioreactors. Vancouver, BC / February 9, 2021 / BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) announces that it is now able to consistently grow Trichomes from multiple cannabis plant strains, in liquid media. Furthermore, BioHarvest
Vancouver, BC / February 4, 2021 / BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) announces that it has signed a financial advisory agreement with Cukierman & Co. Investment House Ltd., a full service Israeli financial advisory firm with life sciences expertise and global capabilities, granting it a mandate to explore opportunities for the
Vancouver, BC / February 2, 2021 / BioHarvest Sciences Inc. (the “Company”, or “BioHarvest”) (CSE: BHSC) announces that it has closed its private placement of units at $0.40 per unit previously announced on January 21, 2021. The private placement was oversubscribed by 449,829 units and the Company has determined to accept the oversubscriptions. A total
